Active Ingredient: SOLIFENACIN SUCCINATE
Proprietary Name: SOLIFENACIN SUCCINATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A209818
Product Number: 002
Approval Date: May 20, 2019
Applicant Holder Full Name: BRECKENRIDGE PHARMACEUTICAL INC
Marketing Status:
Discontinued
Patent and Exclusivity Information